Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Founded in 1999, LASEA provides laser micro-machining solutions to some of the worlds most prestigious companies, including the top three Swiss watchmakers, two GAFA companies, leaders in the eyewear, pharmaceutical and medical industries (intraocular, vascular and